Apyx Medical Corp (APYX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Apyx Medical Corp (APYX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 APYX MEDICAL CORPORATION 2026 SHARE INCENTIVE PLAN Section 1. Purpose. The purposes of the Apyx Medical Corporation 2026 Share Incentive Plan (the “Plan”) are to: (i) aid in maintaining and developing key employees capable of assuring the
How this was made
The 30-second read
Why it matters
Equity incentive plan adoption and officer/director changes can influence internal alignment and future compensation expense patterns, but the provided text does not include grant quantities, financial impact estimates, or operational milestones.
Market read
This is primarily a governance and compensation disclosure. Without additional specifics (who left/was appointed, and any material employment terms), it is unlikely to drive a major repricing.
What to watch
Traders may want to check the full 8-K for the specific director/officer departures, appointments, and any material employment or change-in-control terms, which are not included in the provided excerpt.
Background
The filing is an SEC Form 8-K covering Item 5.02 (director/officer changes and compensatory arrangements) and Item 5.07 (submission of matters to a vote). The excerpt includes the 2026 Share Incentive Plan terms and share pool availability.
Ticker impact
Apyx Medical filed an 8-K for director/officer changes and related compensatory arrangements under its 2026 Share Incentive Plan.
Low likelihood of a sustained price move solely from this filing; any reaction is likely limited to positioning around governance/equity-compensation details.
The excerpt is primarily plan mechanics (share pool size, definitions, administration) tied to officer/director matters. It does not disclose new earnings, guidance, clinical, or deal terms in the provided text.
Market effects
Minimal. Equity incentive plan mechanics are company-specific and do not signal sector-wide regulatory or demand changes in the provided text.
Minimal.
Minimal.
Counterpoint
The share pool size and plan administration could matter if the company is preparing for a near-term hiring or retention push, but the excerpt does not provide grant amounts or timing.
Key entities
- issuerApyx Medical Corp
Subject of the 8-K, including director/officer changes and adoption/terms of the 2026 Share Incentive Plan.
- equity_compensation_plan2026 Share Incentive Plan
Defines awards (options, restricted stock), administration, and sets an aggregate share pool of 4,000,000 shares in the excerpt.
